Victory Capital Management
ARQT icon

Victory Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Victory Capital Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Sell
60,402
-6,036
-9% -$154K ﹤0.01% 1705
2025
Q4 		$1.93M Buy
66,438
+394
+0.6% +$10.1K ﹤0.01% 1595
2025
Q3 		$1.24M Buy
66,044
+34,180
+107% +$539K ﹤0.01% 1741
2025
Q2 		$447K Buy
31,864
+19,257
+153% +$270K ﹤0.01% 2078
2025
Q1 		$197K Sell
12,607
-127
-1% -$1.79K ﹤0.01% 2223
2024
Q4 		$177K Sell
12,734
-109
-0.8% -$1.19K ﹤0.01% 2260
2024
Q3 		$119K Buy
12,843
+1,155
+10% +$11.4K ﹤0.01% 2305
2024
Q2 		$109K Sell
11,688
-487
-4% -$4.4K ﹤0.01% 2285
2024
Q1 		$121K Buy
12,175
+1,756
+17% +$13.1K ﹤0.01% 2280
2023
Q4 		$33.7K Buy
+10,419
New +$28.3K ﹤0.01% 2474
2022
Q4 		– Sell
-25,000
Closed -$478K – 2594
2022
Q3 		$478K Buy
+25,000
New +$566K ﹤0.01% 2073
2020
Q2 		– Sell
-7,720
Closed -$230K – 2552
2020
Q1 		$230K Buy
+7,720
New +$207K ﹤0.01% 2297

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return